Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novichem is a Polish chemical company specializing in the production of high-purity chemical intermediates and Active Pharmaceutical Ingredients (APIs). Founded in 1993 and headquartered in Chorzów, the company serves the pharmaceutical, cosmetic, and technical industries globally. Their core pharmaceutical portfolio includes methenamine salts, such as methenamine hippurate and methenamine mandelate, which are used in treating urinary tract infections. Novichem operates under Good Manufacturing Practice (GMP) standards, ensuring high quality for its pharmaceutical-grade products. In addition to catalog products, the company provides contract manufacturing and custom synthesis services for specialized organic compounds. The firm maintains a strong presence in the European market while exporting its chemical solutions to customers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novichem.